Hyperglycaemia (Diabetic): Clinical Trials

3 trials for Hyperglycaemia (Diabetic), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1
Phase 21Recruiting 1

Follow Hyperglycaemia (Diabetic): new trials by email Literature Review of Hyperglycaemia (Diabetic) trials Research Report on Hyperglycaemia (Diabetic)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis
Phase 1 / Phase 2RecruitingDavid K Carroll602025-12-192026-02-12
Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus
Globalagliatin Hydrochloride, Placebo - Hyperglycaemia (Diabetic), Type 2 Diabetes Mellitus
Phase 1CompletedYabao Pharmaceutical Group242018-01-032020-01-03
The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydrochloride
globalagliatin hydrochloride, placebo - Hyperglycaemia (Diabetic), Healthy Volunteers
Phase 1CompletedYabao Pharmaceutical Group442017-04-052018-01-31

Narrower conditions

Hyperglycemia (3)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Ketoacidosis (1)

Broader conditions

Endocrine System Diseases (3)  ·  Glucose Metabolism Disorders (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Autoimmune Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Immune System Diseases (1)  ·  Ketosis (1)

Interventions

Arginine (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

Yabao Pharmaceutical Group (2)  ·  David K Carroll (1)

Countries

China (2)  ·  United States (1)

Top investigators

Lei Yang (2)

Results publications

PMID 33125674, PMID 35093240